Morgan Stanley’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Buy
19,858
+26
+0.1% +$162 ﹤0.01% 6168
2026
Q1
$97.8K Sell
19,832
-597
-3% -$3.06K ﹤0.01% 6177
2025
Q4
$120K Buy
20,429
+515
+3% +$4.28K ﹤0.01% 6117
2025
Q3
$120K Buy
19,914
+1,858
+10% +$8.82K ﹤0.01% 6070
2025
Q2
$70.6K Buy
18,056
+125
+0.7% +$407 ﹤0.01% 6247
2025
Q1
$55.2K Buy
17,931
+1,000
+6% +$4.53K ﹤0.01% 6239
2024
Q4
$89.9K Hold
16,931
﹤0.01% 6098
2024
Q3
$77.7K Sell
16,931
-1
-0% -$5 ﹤0.01% 6089
2024
Q2
$121K Hold
16,932
﹤0.01% 5898
2024
Q1
$144K Sell
16,932
-16,932
-50% -$146K ﹤0.01% 5851
2023
Q4
$201K Buy
33,864
+16,832
+99% +$147K ﹤0.01% 5948
2023
Q3
$169K Buy
17,032
+50
+0.3% +$693 ﹤0.01% 5659
2023
Q2
$299K Buy
16,982
+16,668
+5,308% +$325K ﹤0.01% 5466
2023
Q1
$7.11K Sell
314
-523
-62% -$13.6K ﹤0.01% 6979
2022
Q4
$16.7K Buy
837
+170
+25% +$3.94K ﹤0.01% 6750
2022
Q3
$37K Sell
667
-2,420
-78% -$160K ﹤0.01% 6540
2022
Q2
$156K Sell
3,087
-1,792
-37% -$100K ﹤0.01% 6011
2022
Q1
$385K Buy
4,879
+1,515
+45% +$91.7K ﹤0.01% 5563
2021
Q4
$276K Buy
3,364
+2,315
+221% +$248K ﹤0.01% 5886
2021
Q3
$143K Buy
1,049
+338
+48% +$57.7K ﹤0.01% 6178
2021
Q2
$160K Buy
711
+606
+577% +$128K ﹤0.01% 6120
2021
Q1
$27K Buy
105
+55
+110% +$12.1K ﹤0.01% 6606
2020
Q4
$9K Buy
+50
New +$11K ﹤0.01% 6651
2019
Q2
Sell
-5
Closed -$1K 6653
2019
Q1
$1K Hold
5
﹤0.01% 6505
2018
Q4
$1K Hold
5
﹤0.01% 6487
2018
Q3
$1K Buy
+5
New +$967 ﹤0.01% 6615

Other funds holding CLNN

Morgan Stanley's CLNN Position: Q2 2026 in Review

Morgan Stanley increased its Clene (CLNN) stake by 0.13% in Q2 2026, buying an estimated $162 and bringing the position to 19,858 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #6168.

Morgan Stanley first reported a position in CLNN in Q3 2018 and has held it in 26 quarters since. The position peaked at $385K in Q1 2022. 21 funds tracked by Wall St. Rank hold CLNN as of Q2 2026.

  • Morgan Stanley held 19,858 shares of Clene worth $122K as of Q2 2026.
  • Morgan Stanley bought 26 Clene shares in Q2 2026, an estimated $162.
  • Clene made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6168 holding.
  • Morgan Stanley first reported a position in Clene in Q3 2018 and has held it in 26 quarters since.
  • Morgan Stanley's Clene position peaked at $385K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Clene as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.